Statin-associated new-onset diabetes mellitus and insulin resistance: a 30-year bibliometric study (1992- 2022)
Statins are widely used lipid-lowering drugs that are relatively well-tolerated and have an established safety profile. However, statin therapy has been reported to increase the risk of developing new-onset type 2 diabetes mellitus (NOD2). Although this side effect is rare, research on this topic is...
| 出版年: | Biomedical Research and Therapy |
|---|---|
| 第一著者: | |
| フォーマット: | Review |
| 言語: | English |
| 出版事項: |
BiomedPress
2023
|
| オンライン･アクセス: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85192647030&doi=10.15419%2fbmrat.v10i11.845&partnerID=40&md5=82bdb2aefc20f9440b975365c0cd4451 |